Inovio Pharmaceuticals Inc. (INO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Inovio Pharmaceuticals In...

    NASDAQ: INO · Real-Time Price · USD
    2.48
    0.05 (2.06%)
    At close: Sep 26, 2025, 3:59 PM
    2.47
    -0.38%
    After-hours: Sep 26, 2025, 06:49 PM EDT

    Inovio Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 65.81M 14.31M 46.33M 71.14M
    Short-Term Investments
    		 28.3M 130.98M 206.67M 330.17M
    Long-Term Investments
    		 1.61M 2.78M 2.01M 3.91M
    Other Long-Term Assets
    		 3.68M 605.32K 684.04K 1.43M
    Receivables
    		 1.2M 2.41M 11.74M 8.03M
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 n/a 20.43K 30.38M 261.19K
    Total Current Assets
    		 97.83M 153.11M 315.24M 448.44M
    Property-Plant & Equipment
    		 11.77M 14.45M 17.96M 29.02M
    Goodwill & Intangibles
    		 n/a n/a 12.64M 13.14M
    Total Long-Term Assets
    		 17.07M 17.84M 33.29M 47.5M
    Total Assets
    		 113.2M 170.95M 348.53M 495.94M
    Account Payables
    		 6.44M 4.65M 21.08M 27.97M
    Deferred Revenue
    		 n/a n/a n/a 21.63K
    Short-Term Debt
    		 2.5M 16.77M 2.8M 2.6M
    Other Current Liabilities
    		 23.89M 9.95M 12.33M 18.11M
    Total Current Liabilities
    		 35.33M 42.57M 96.87M 65.74M
    Long-Term Debt
    		 n/a n/a 16.61M 14.96M
    Other Long-Term Liabilities
    		 n/a n/a -16.61M 14.83K
    Total Long-Term Liabilities
    		 9.37M 11.03M 29.3M 30.53M
    Total Liabilities
    		 44.69M 53.6M 126.17M 96.27M
    Total Debt
    		 11.87M 30.21M 32.07M 33.02M
    Book Value
    		 68.5M 117.35M 222.36M 399.67M
    Book Value Per Share
    		 2.52 5.29 11.18 1.86
    Common Stock
    		 36.1K 22.79K 253.09K 217.38K
    Retained Earnings
    		 -1.73B -1.62B -1.49B -1.21B
    Comprehensive Income
    		 -675.67K -662.6K -698.74K -282.24K
    Shareholders Equity
    		 68.5M 117.35M 222.36M 399.67M
    Total Investments
    		 29.91M 133.76M 208.68M 334.08M

    Add to Watchlist